NIH-funded research NIH-funded research

Harnessing Copper-Linked Pathways to Build Complex Heterocycles

Official title: Leveraging σ-alkyl Metal Complexes for the Cascade Synthesis of Heterocyclic Scaffolds

Funded at New York University · NIH-11423759 · Data updated 2026-11-12

A project at NYU will develop new copper-catalyzed methods to rapidly assemble oxygen- and nitrogen-containing ring systems that appear in many medicines and natural products.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNew York University
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2026
Project endApril 30, 2031
Funding year2026
Award (this year)$392,356
NIH project number1R35GM165397-01
Project IDNIH-11423759 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with interests in advanced medicinal chemistry and who may benefit indirectly from faster creation of new therapeutics.

Less likely to help

Direct patient benefit is not guaranteed; the project is a foundational chemistry effort that may influence future therapies.

What this research studies

This research aims to create fast, efficient ways to build intricate heterocycles by using copper to trigger cascade reactions that combine C–H activation, group shifts, and ring formation. The team has already shown that σ-alkyl copper intermediates can enable radical migrations and that aziridines and epoxides can couple to form spirocycles without extra oxidants. The approach could provide versatile scaffolds with handles for further modifications, potentially speeding drug discovery. The work blends novel chemistry with practical routes to bioactive compounds, aiming to expand access to advanced molecular architectures.

Why it matters

Potential benefit: If successful, patients could benefit from faster development of new medicines built on these diverse heterocycles.

How similar studies have gone: Preliminary results show promising radical relay strategies and intermolecular/intramolecular couplings, suggesting potential for practical application.

Where this research is happening

  • New York University
    New York, United States
    Active

Researchers

  • Principal investigator: Tomanik, Martin — New York University
  • Study coordinator: Tomanik, Martin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.